H. L. A. Janssen

Hepatitis B and D: Interferon-Based Therapy-For Clinical Trials or Standard of Care-Back to the Future?

Interferon (IFN) has historically played a major role in chronic viral hepatitis B and D management over the last three decades. Widening utilisation of nucleoside/nucleotide analogues (NUCs) for hepatitis B viral suppression, which have a better side-effect profile, alongside the recent licensing of bulevirtide for tr...